Nurse Practitioner, Family · Richmond, IN
NPI
1760883847
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1050 Reid Pkwy Ste 130
Richmond, IN, 47374
Phone (765) 935-8943
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
1,222 services
Medicare patients, 2024
522
Average age 73
Drug cost, 2024
$3.1M
7,157 prescriptions
Company payments, 2025
$1,047
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendi Shaffmaster was code 99213 (office e&m - established), 453 times for 363 patients. In total Wendi Shaffmaster billed 1,222 services in 12 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 453 | 363 | $50.68 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 306 | 232 | $9.98 | $3,054 |
| 99214 Office E&M - Established | Office | 278 | 234 | $75.01 | $21K |
| 99407 Behavioral Health Services | Office | 127 | 86 | $21.46 | $2,725 |
| 99215 Office E&M - Established | Office | 24 | 23 | $103.64 | $2,487 |
| 99204 Office E&M - New | Office | 13 | 13 | $81.42 | $1,058 |
By year: 2022 $80K for 1,332 services; 2023 $60K for 1,086 services; 2024 $53K for 1,222 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wendi Shaffmaster prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,617 prescriptions and refills. In total Wendi Shaffmaster wrote 7,157 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,617 | 1,981 | 431 | $51K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,531 | 2,013 | 289 | $1.3M |
| Prednisone Generic | 529 | 566 | 274 | $1,346 |
| Montelukast Sodium Generic | 447 | 860 | 93 | $3,005 |
| Breo Ellipta Fluticasone/Vilanterol | 388 | 498 | 71 | $197K |
| Ventolin Hfa Albuterol Sulfate | 342 | 425 | 106 | $25K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 334 | 375 | 62 | $234K |
| Doxycycline Hyclate Generic | 180 | 180 | 126 | $1,375 |
| Levofloxacin Generic | 162 | 162 | 103 | $544 |
| Spiriva Respimat Tiotropium Bromide | 158 | 211 | 33 | $109K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 131 | 187 | 45 | $18K |
| Symbicort Budesonide/Formoterol Fumarate | 130 | 150 | 30 | $35K |
| Azithromycin Generic | 91 | 91 | 66 | $313 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 89 | 115 | 21 | $52K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 75 | 93 | 22 | $10K |
Brand drugs: 4,819 claims; generic drugs: 2,338 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendi Shaffmaster $1,047 ($1,047 in general payments such as food, travel and fees) from 14 companies. The largest payer was GlaxoSmithKline, LLC. with $272.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 21 | $272 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $243 |
| Genzyme Corporation SNY | 8 | $146 |
| Baxter Healthcare BAX | 2 | $63.78 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $52.73 |
| Amgen Inc. AMGN | 2 | $48.39 |
| Verona Pharma, Inc. VRNA | 3 | $45.29 |
| Insmed, Inc. INSM | 2 | $38.78 |
| Viatris Specialty LLC | 2 | $37.68 |
| Grifols USA, LLC | 1 | $31.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.